Evaro
PrivateLast Round
Series A
Jan 27, 2026
Total Funding Raised
$26.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Evaro is a healthcare technology company that provides a B2B pharmaceutical infrastructure-as-a-service platform, enabling consumer brands to seamlessly integrate prescription medication services into their offerings.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Vertical SaaS, Patient Engagement, Workflow Automation, API Management
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evaro Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Evaro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 27, 2026 | ||||
| Seed | Jan 31, 2024 |
Key People
Founding team and executive leadership
Evaro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Simplyhealth Ventures | Series A |
| University of East Anglia | Seed |
| Exceptional Ventures | Series A, Seed |
| Catalisi | Seed |
| Cornerstone VC | Series A, Seed |
| Albion Capital | Series A |
| British Business Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2026
$25M round completed.
- Jan 27, 2026
Christoph Ruedig joins the board of directors.
Evaro Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evaro's valuation, stock price, and market status.